Marrone Bio Innovati
MBII
Delayed Nasdaq - 08/18 09:58:31 pm
0.958USD
+3.01%
Upcoming events
08/24/17 | 17:30
Southern California Investor Conference
Past Events
08/14/17 | 10:30pmInterim 2017 Earnings Call
08/14/17Interim 2017 Earnings Release
08/07/17 | 08:20pmJefferies Global Industrials Conference
06/15/17 | 09:30pmNasdaq Investor Program
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread
14,0
14,6
-3,6%

22,3
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-21,4
-20,5
-4,4%

-19,1
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-23,7
-23,8
0,76%

-21,7
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-31,1
-30,5
-1,7%

-28,7
Net income
Million $
Released
Forecast
Spread
-31,1
-30,5
-1,7%

-28,7
EPS
 $
Released
Forecast
Spread
-1,26
-1,14
-11%

-1,01
Announcement Date03/29/2017
Quarterly / Semiannualy publications
Quarterly resultsQ2
2017
Q3
2017 (e)
Sales
Million $
Released
Forecast
Spread
6,48
7,06
-8,3%

5,11
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-4,90
-3,97
-24%

-4,64
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-5,42
-5,01
-8,0%

-5,44
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-7,39
-6,78
-8,9%

-7,25
Net income
Million $
Released
Forecast
Spread
-7,39
-6,78
-8,9%

-7,25
EPS
 $
Released
Forecast
Spread
-0,25
-0,21
-22%

-0,24
Announcement Date08/14/2017
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise